News/Stealth Agents Research

Dry Eye Specialty Clinic Virtual Assistant: How a Virtual Assistant Handles Treatment Protocol Tracking and Patient Communication

Stealth Agents·

Dry eye disease is the fastest-growing diagnostic category in optometry and ophthalmology. The Tear Film & Ocular Surface Society (TFOS) estimates that 16% of the US adult population has symptomatic dry eye disease, and the specialty clinic market built around LipiFlow thermal pulsation, intense pulsed light (IPL), and prescription immunomodulatory drops has grown accordingly. But dry eye treatment is not a single-visit solution — it is a multi-step, multi-month management protocol that generates ongoing contact with each patient. Keeping that contact systematic is where most practices fall short. A virtual assistant for dry eye specialty clinics makes protocol management scalable.

Treatment Protocol Tracking Across Multiple Modalities

A comprehensive dry eye patient may be on a protocol that includes in-office LipiFlow or IPL treatments every 3–4 months, daily prescription drops (Restasis, Xiidra, Cequa, or Tyrvaya), and adjunct therapies including warm compresses, omega-3 supplementation, and lid hygiene. Tracking where each patient is in their protocol — and when their next treatment or recheck is due — requires a structured system that most practices do not have.

A virtual assistant maintains a dry eye treatment tracker for each active patient: logging in-office treatment dates, confirming upcoming treatment appointments, and generating outreach at appropriate protocol intervals. For LipiFlow patients, the VA initiates outreach at the 3-month mark to schedule the follow-up TearLab or LipiView assessment and recommend the next treatment cycle based on the practice's protocol. For IPL patients managed under platforms like OptiLight or Lumenis M22, the VA tracks the series completion and books the maintenance treatment at the 12-month interval.

Prior Authorization for Restasis, Xiidra, and Cequa

Prescription immunomodulatory drops for dry eye — Restasis (cyclosporine 0.05%), Xiidra (lifitegrast 5%), and Cequa (cyclosporine 0.09%) — are among the most commonly denied prescriptions under commercial insurance plans. Payers typically require documented failure of OTC artificial tears, a confirmed diagnosis code (H04.123 or equivalent), and sometimes a step-therapy requirement through a lower-cost alternative before approving the branded prescription.

A virtual assistant prepares and submits prior authorization requests for dry eye prescriptions: pulling the clinical justification from the EHR, documenting the required step-therapy history, and submitting through payer portals or CoverMyMeds. When denials occur, the VA prepares the peer-to-peer review request with supporting clinical literature — including TFOS DEWS II data on prescription drop efficacy — and routes it to the physician queue for call completion. Practices that systematize this process see approval rates increase significantly over ad hoc appeal submissions.

Symptom Check-In Communication Between Visits

Dry eye management between formal visits relies on patient self-reporting. Patients who experience treatment failure, adverse reactions to drops, or symptom breakthrough between appointments often do not call — they simply stop using their prescribed therapy and deteriorate. Systematic mid-cycle check-ins identify these patients before they present at their next visit with undertreated disease.

A virtual assistant conducts structured symptom check-ins at 4-week intervals for active dry eye patients using the OSDI (Ocular Surface Disease Index) questionnaire or a simplified practice-specific form. Patients with worsening scores are flagged for earlier re-evaluation; patients doing well receive motivational messaging reinforcing compliance. This check-in system is particularly valuable for patients on Xiidra, which has a commonly reported burning sensation side effect that leads to early discontinuation when not proactively managed.

Diagnostic Testing Recall and Meibography Follow-Up

Advanced dry eye diagnostics — TearLab osmolarity, InflammaDry, LipiView meibography, and corneal topography — are performed at specific intervals in the treatment protocol. Scheduling these assessments, confirming insurance coverage, and communicating results to patients in plain language is administrative work that falls between clinical and front desk responsibilities.

A virtual assistant schedules diagnostic testing at appropriate protocol intervals, confirms insurance coverage for each test (meibography and osmolarity testing face varying payer coverage policies), and prepares plain-language results summaries for patient communication after the treating provider reviews findings.

Dry eye specialty practices managing multiple device platforms and prescription management workflows can scale with VA support from Stealth Agents, which places VAs trained in chronic ocular surface disease management protocols.

The Revenue Case for Dry Eye Protocol Adherence

In-office dry eye treatment revenue is highly recurring — a well-managed LipiFlow patient represents $1,200–$1,800 in annual treatment revenue across two to three sessions. A virtual assistant who retains even 10 additional active dry eye patients per year through systematic follow-up generates $12,000–$18,000 in incremental revenue.

Sources